Isolation of cytomegalovirus (CMV) in tissue culture is presently the most reliable means of proving active CMV infection. To improve both the costeffectiveness and clinical usefulness of procedures for the isolation of CMV from fresh clinical specimens, we analyzed results obtained with standard isolation procedures and compared them with results obtained under different conditions. Cell monolayers from commercial sources were inoculated with fresh specimens and then were observed for a cytopathic effect typical of CMV. Of 1,375 specimens submitted over a 12-month period, 6.4% were CMV positive in WI-38 monolayers within 28 days after inoculation. The mean day of CMV detection for 45 urine, 13 cervical-vaginal, and 5 saliva specimens was 6.7 ± 3.1 (mean ± standard deviation), 9.9 ± 3.3, and 7.7 ± 3.3 days, respectively, and 92% were positive within 14 days. When (2, 3, 5, 12) . The diagnosis of CMV infection usually requires laboratory confirmation and cannot be made on clinical grounds alone. At the present time, the most reliable means available for proving active CMV infection is isolation of the virus in tissue culture (9, 13). Human fibroblasts were first used for the isolation of CMV in 1956 (10, 11), and it has since been shown that productive infection generally occurs only in cells of human origin. Monolayers of WI-38 cells, diploid embryonic lung cells, are widely used by diagnostic laboratories, but it is becoming increasingly difficult to obtain this cell line in low passages (14). In a search for an acceptable alternative to WI-38 cells for the detection of CMV, WI-38 cells were compared with another well-characterized commercially available diploid cell line derived 
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Specimens received on swabs were treated similarly after agitation and compression of the swab to suspend the specimen in transport medium. Heparinized blood specimens were allowed to settle in an inverted syringe. After 1 to 2 h, the plasma layer containing mixed leukocytes was aspirated from the top of the syringe and centrifuged at low speed, and the suspended pellet was used as an inoculum. Tissue specimens, such as liver biopsy material, were homogenized by grinding. The resulting suspension was centrifuged, and the supernatant fluid was used as an inoculum. Tubes inoculated with tissue suspension and blood specimens were washed with fresh medium 2 to 3 h after inoculation. Medium was changed in all culture tubes on day 1 and then every seventh day after set-up.
Organization of study. This prospective study was undertaken in two segments. In the first segment, specimens were inoculated onto a single tube of WI-38 cells and then incubated at 36°C for 28 days. In the second segment, one tube of WI-38 cells was compared with one tube of MRC-5 cells over a 14-day period for susceptibility to CMV infection and speed of development of viral cytopathic effect after inoculation with fresh clinical specimens.
Tightly sealed culture tubes were incubated at 36°C on a roller drum (0.2 rpm). Morphological characteristics of monolayers were examined (x40 magnification) daily for the first 7 days (except Sunday) of incubation, then every second to third day thereafter. Identification of CMV was by typical cytopathic effect (9) Overall, the mean day of initial observation of CMV cytopathic effect was 7.4 days after inoculation. However, the mean day of positive findings varied with the specimen type ( Table 2) . When all positive results were compared, CMV was detected significantly earlier in MRC-5 cells than in WI-38 cells (P < 0.001, McNemar test). When analyzed by specimen type, the observed difference was meaningful only for urine specimens. Positive specimens from sources other than those listed in Table 2 included one nasopharyngeal swab, one urethral swab, and one sputum specimen; these were positive on days 7, 9, and 13, respectively.
The distribution of CMV-positive cultures was analyzed for each of 12 consecutive months. Little seasonal variation was found (data not shown). Thirty-eight specimens, just over half of the total, were positive in both cell lines on the same day after inoculation. However, 38% (26 specimens) yielded positive results earlier or only in MRC-5 cultures. Sixteen specimens were positive an average of 4.8 days (range, 1 to 8 days) earlier in MRC-5 cells. Ten MRC-5-positive specimens were not detected in WI-38 cells within the 14-day incubation period. Three specimens were positive earlier in WI-38 cells by an average of 3.7 days, and only one specimen was positive in WI-38 cells and not in MRC-5 cells. These observed differences were not clustered, and lot-to-lot variability of susceptibility of either cell line was not apparent.
WI-38 and MRC-5 cells were compared for the length of time it took to isolate CMV from urine specimens of different patient groups (Fig. 2) . When 15 specimens from 11 infants were cultured, the mean time to initial detection of CMV cytopathic effect was 4.5 days in MRC-5 cells, compared with 5.2 days in WI-38 cells. All An incubation period of at least 4 weeks before discarding a negative culture is recommended in many protocols for CMV isolation (4, 9) . We found that 92% of 88 CMV isolates were detected in WI-38 cells within the first 2 weeks of incubation. To improve the cost-effectiveness of our protocol, the five tube readings beyond day 14 and the fluid changes on days 14 and 21 were eliminated. This resulted in a reduction of laboratory operating costs and provided the additional time necessary for processing new specimens. At the same time, a sensitivity of greater than 90o was retained for the 14-day procedure when compared with the 28-day procedure in our laboratory.
In an earlier study, Friedman and Koropchak (4) concluded that the speed of CMV cytopathic effect development was the same in WI-38 and MRC-5 cell cultures. That study used cells inoculated with samples of seven frozen urine specimens previously positive in WI-38 cells. Our analysis of 57 specimens positive in both cell lines is essentially in agreement (data not shown). However, the data we present indicate that 16% more positive specimens were detected VOL. 17, 1983 on October 18, 2017 by guest http://jcm.asm.org/ Downloaded from 
of days ± standard deviation) from inoculation to initial observation of CPE in all positive cultures of each specimen type. The observed differences between these categories are significant (two-tailed t test): urine and cervical-vaginal (P < 0.01), urine and liver (P < 0.02), cervical-vaginal and liver (P < 0.001), and saliva and liver (P < 0.05).
b Number of cultures in which typical CMV CPE was observed as indicated. Total length of observation was 14 days. The observed difference between MRC-5 and WI-38 cultures is significant for urine (P < 0.001, McNemar test), but not for cervical-vaginal specimens (P = 0.15, Fisher exact test) or saliva (P = 0.08, Fisher exact test).
in MRC-5 cultures than in cultures of WI-38 cells. A trend towards earlier positive results in MRC-5 cells was also observed. These gains can be viewed as distinct contributions to the efficiency of the procedure, and they may even offset the 8% reduction in positive results sustained by restricting the incubation period to 14 days. Overall, 38% of 68 isolates were positive earlier or only in MRC-5 cells. Furthermore, the 26 specimens that yielded positive results earlier or only in MRC-5 cultures were well distributed throughout the year, reducing the probability of extreme variability in susceptibility of cells in particular commercial shipments. The lack of seasonal variation in CMV isolation is consistent with what is known about the epidemiology and transmission of this virus (1) (2) (3) .
The apparent differences in mean day to first cytopathic effect observed in our study versus that of Friedman and Koropchak (4) may not be real differences and may only reflect the timing of culture reading, the type of specimens examined, or the effects of storage. They reported a mean day of onset of cytopathic effect of 10.4 and 8.4 days for WI-38 and MRC-5 cells, respectively, when cultures were examined twice a week (4) . In comparison, when we analyzed the temporal appearance of cytopathic effect for 45 isolates of CMV from fresh urine specimens, the mean day of first appearance in the same two cell lines was 7.2 and 6.3 days, respectively. Our tubes were read daily for the first Decreasing the incubation time (from 28 to 14 days) and the number of tubes inoculated (from 2 to 1) reduced the cost to our laboratory of culturing specimens for CMV by approximately 40%o without greatly affecting the overall efficiency of the procedure. The savings realized were in terms of technologist time, the cost of cell culture tubes, and the materials used for culture maintenance. Each laboratory should review its CMV isolation results before making significant procedural changes since a number of variables including age and immune status of the patient, the type of specimen, and storage may influence the speed and rate of CMV recovery. It appears reasonable, however, for diagnostic virology laboratories to consider using single tube cultures of MRC-5 cells, incubated for 2 weeks at 36°C, for the routine isolation of CMV. Attempts to isolate other viruses should include other protocols, as appropriate.
